Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation

Therapeutic Apheresis

Volumn 3, Issue 3, 1999, Pages 252-256

  Bosch, T ^a,b   Buhmann, R ^a   Lennertz, A ^a   Samtleben, W ^c   Kolb, H J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NONE

Author keywords

Bone marrow transplant thrombotic microangiopathy; Bone marrow transplantation; Cryosupernatant; Therapeutic plasma exchange; Thrombotic microangiopathy

Indexed keywords

CYCLOSPORIN A; FRESH FROZEN PLASMA;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; CACHEXIA; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SUPERNATANT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PILOT PROJECTS; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 0032792850     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00168.x     Document Type: Article

References (16)

1. Kanamori H, Maruta A, Sasaki S, Yamazaki E, Ueda S, Katoh K, Tamura T, Otsuka-Aoba M, Taguchi J, Harano H, Ogawa K, Mohri H, Okubo T, Matsuzaki M, Watanabe S, Koharazawa H, Fujita H, Kodama F. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy Bone Marrow Transplant 1998; 21:705-9.
2. Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, Lehmacher W, Ruckdeschel G, Gleixner B, Riedner C, Ledderose G, Brehm G, Mittermüller J, Wilmanns W. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75;1011-6.
3. Schriber JR, Herzig GP. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997;34:126-33.
4. Zomas A, Saso R, Powles R, Mackay H, Sinhal L, Treleaven J, Mehta J. Red cell fragmentation (schistocytosis) after bone marrow transplantation. Bone Marrow Transplant 1998;22: 777-80.
5. Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998;22:351-7.
6. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14:495-504.
7. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS. Bone marrow transplant-associated thrombotic microangiopathy: A case series. Bone Marrow Transplant 1995;15:247-53.
8. Zeigler ZR, Shadduck RK, Nath R, Andrews III DF. Pilot study of combined cryosupernatant and protein A immunoadsoption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 1996;17:81-6.
9. Rock GA, Shumak KH, Buskard NA. Comparison of plasma exchange with plasma infusion in the treatment of thrombic thrombocytopenic purpura. N Engl J Med 1991;325:393-403.
10. Moake JL. Moschcowitz, multimers, and metalloprotease. N Engl J Med 1998;339:1629-31.
11. Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B, Seeber Ch, Jehn U, Gerhartz HH, Brehm G, Wilmanns W. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73:2018-24.
12. Holler E, Kolb HJ, Mittermüller J, Kaul M, Ledderose G, Duell Th, Seeber B, Schleuning M, Hintermeier-Knabe R, Ertl B, Kempeni J, Wilmanns W. Modulation of acute graft-versus-host disease after allogneic bone marrow transplantation by tumor necrosis factor alpha (TNFalpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNFalpha (MAK 195F). Blood 1995;86:890-9.
13. Tandon N, Rock G, Jamieson GA. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura Br J Haematol 1994; 88:816-25.
14. Milone J, Napal J, Bordone J, Etchegoyen O, Morales V. Complete response in severe thrombotic microangiopathy post bone moarrow transplantation (BMT-TM) after multiple plasmaphereses. Bone Marrow Transplant 1998;22:1019-21.
15. Byrnes JJ, Moake JL, Klug P, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990;34:169-74.
16. Obrador GT, Zeigler ZR, Shadduck RK, Rosenfeld CS, Hanrahan JB. Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura. Am J Hematol 1993;42:217-20.